UPDATE: Raymond James Downgrades Galmed Pharmaceuticals (GLMD) to Market Perform
Tweet Send to a Friend
(Updated - May 18, 2022 5:10 AM EDT)
Raymond James analyst Steven Seedhouse downgraded Galmed Pharmaceuticals (NASDAQ: GLMD) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Steven Seedhouse downgraded Galmed Pharmaceuticals (NASDAQ: GLMD) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
